Live News EARNINGS ARTICLE L impact Aug 06, 2026, 08:13 PM UTC

TriSalus Life Sciences Affirms FY2026 Sales Guidance of $54.000M-$57.000M vs $52.396M Est

TriSalus Life Sciences (NASDAQ: TLSI ) affirms FY2026 sales outlook from $54.000 million-$57.000 million to $54.000 million-$57.000 million vs $52.396 million estimate.

TLSI

SquawkNews Newsroom

TriSalus Life Sciences (NASDAQ: TLSI ) affirms FY2026 sales outlook from $54.000 million-$57.000 million to $54.000 million-$57.000 million vs $52.396 million estimate.